Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry J Hoffer

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
Journal of Neuroscience Methods|June 27, 2016
EditorialBarry J Hoffer
Experimental Neurology|May 11, 2011
Commentary on chronic infusion of CDNF prevents 6-OHDA-induced deficits in a rat model of Parkinson's disease. Merja H. Voutilainen et alBarry J Hoffer
Nature Reviews. Neurology|September 21, 2011
Is GDNF beneficial in Parkinson disease?Barry J Hoffer, Brandon K Harvey
Pharmacology & Therapeutics|January 27, 2005
Stroke and TGF-beta proteins: glial cell line-derived neurotrophic factor and bone morphogenetic proteinBrandon K Harvey, Barry J Hoffer, Yun Wang
Behavioural Brain Research|July 5, 2003
Elevated locomotor activity without altered striatal dopamine contents in Nurr1 heterozygous mice after acute exposure to methamphetamineCristina Bäckman, Zhi Bing You, Thomas Perlmann, et al.
Scientific Reports|October 10, 2014
Maternally transmitted mitochondrial DNA mutations can reduce lifespanJaime M Ross, Giuseppe Coppotelli, Barry J Hoffer, et al.
Journal of Neuroscience Methods|December 9, 2003
Short interfering RNAs (siRNAs) for reducing dopaminergic phenotypic markersCristina Bäckman, YaJun Zhang, Barry J Hoffer, et al.
Journal of Neuroscience Methods|October 19, 2004
Tetracycline-inducible expression systems for the generation of transgenic animals: a comparison of various inducible systems carried in a single vectorCristina M Bäckman, YaJun Zhang, Barry J Hoffer, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|October 9, 2010
Transgenic animal models of neurodegeneration based on human genetic studiesBrandon K Harvey, Christopher T Richie, Barry J Hoffer, et al.
Parkinsonism & Related Disorders|November 19, 2008
Neurotrophic factors for the treatment of Parkinson's diseaseMatthew J Chiocco, Brandon K Harvey, Yun Wang, et al.
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
Journal of Neuroscience Methods|June 27, 2016
EditorialBarry J Hoffer
Experimental Neurology|May 11, 2011
Commentary on chronic infusion of CDNF prevents 6-OHDA-induced deficits in a rat model of Parkinson's disease. Merja H. Voutilainen et alBarry J Hoffer
Nature Reviews. Neurology|September 21, 2011
Is GDNF beneficial in Parkinson disease?Barry J Hoffer, Brandon K Harvey
Pharmacology & Therapeutics|January 27, 2005
Stroke and TGF-beta proteins: glial cell line-derived neurotrophic factor and bone morphogenetic proteinBrandon K Harvey, Barry J Hoffer, Yun Wang
Behavioural Brain Research|July 5, 2003
Elevated locomotor activity without altered striatal dopamine contents in Nurr1 heterozygous mice after acute exposure to methamphetamineCristina Bäckman, Zhi Bing You, Thomas Perlmann, et al.
Scientific Reports|October 10, 2014
Maternally transmitted mitochondrial DNA mutations can reduce lifespanJaime M Ross, Giuseppe Coppotelli, Barry J Hoffer, et al.
Journal of Neuroscience Methods|December 9, 2003
Short interfering RNAs (siRNAs) for reducing dopaminergic phenotypic markersCristina Bäckman, YaJun Zhang, Barry J Hoffer, et al.
Journal of Neuroscience Methods|October 19, 2004
Tetracycline-inducible expression systems for the generation of transgenic animals: a comparison of various inducible systems carried in a single vectorCristina M Bäckman, YaJun Zhang, Barry J Hoffer, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|October 9, 2010
Transgenic animal models of neurodegeneration based on human genetic studiesBrandon K Harvey, Christopher T Richie, Barry J Hoffer, et al.
Parkinsonism & Related Disorders|November 19, 2008
Neurotrophic factors for the treatment of Parkinson's diseaseMatthew J Chiocco, Brandon K Harvey, Yun Wang, et al.
Pageof 13